Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism

Status Active, not recruiting

Clinical Trial Summary

A study to determine the possibility of using far infrared radiation to treat Hyperparathyroidism.

Clinical Trial Description

Overactive parathyroid glands secrete an excess of parathyroid hormones, resulting in increased levels of calcium in the blood stream, which can lead to weakening of the bones and to kidney stones.

We are postulating that the non-invasive energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to stop the over secretion of the parathyroid hormones and normalize the body's metabolic functions. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Hyperparathyroidism

Clinical Trial Details

NCT number	NCT00573573
Study type	Interventional
Source	GAAD Medical Research Institute Inc.
Contact
Status	Active, not recruiting
Phase	Phase 1
Start date	January 2007
Completion date	July 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00379899` - ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis	Phase 4
Completed	`NCT00377312` - 7 Day Continuous Parathyroid Hormone IV Infusion	Phase 0
Completed	`NCT04040946` - Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention	Phase 3
Recruiting	`NCT03053999` - Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
Withdrawn	`NCT02711059` - Insulin Resistance in Primary Hyperparathyroidism	N/A
Completed	`NCT01691781` - The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study	N/A
Completed	`NCT00538720` - Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)	Phase 1
Completed	`NCT00887666` - Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure	N/A
Terminated	`NCT03044600` - Gene Expression in Hyperparathyroidism
Completed	`NCT03747029` - Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study
Completed	`NCT01872429` - Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients	N/A
Completed	`NCT00800358` - Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism	N/A
Recruiting	`NCT00169806` - Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis	N/A
Completed	`NCT03968510` - Swalqol in Primary Hyperparathyroidism
Completed	`NCT00501215` - Effect of Parathyroidectomy on Sleep	N/A
Completed	`NCT02591160` - Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism	N/A
Recruiting	`NCT05299632` - F-18 PSMA for Localization of Parathyroid Adenoma
Recruiting	`NCT02986607` - Corticosteroid Rhythms in Hypoparathyroid Patients	Early Phase 1
Completed	`NCT02432599` - Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas	Phase 2
Completed	`NCT02524041` - Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism	N/A